[1] CHOI H J, CHO S J, KIM O, et al. Efficacy and safety of a novel topical agent for gallstone dissolution: 2-methoxy-6-methylpyridine[J]. J Transl Med, 2019, 17(1):195.
[2] 顾树南, 蔡珍福, 王坚. 胆结石灌注药物溶石的治疗进展[J]. 中华现代外科学杂志, 2005, 2(5):431-434.
[3] YOU D D, CHO S J, KIM O, et al. Superior gallstone dissolubility and safety of tert-amyl ethyl ether over methyl-tertiary butyl ether[J]. WJG, 2019,25(39):5936-5952.
[4] JAUNOO S S, MOHANDAS S, ALMOND L M. Postcholecystectomy syndrome (PCS)[J]. Int J Surg, 2010, 8(1):15-17.
[5] NOGUEIRA L, FREEDMAN N D, ENGELS E A, et al. Gallstones, cholecystectomy, and risk of digestive system cancers[J]. Am J Epidemiol, 2014, 179(6):731-739.
[6] QIAO T, MA R, LUO X, et al. The systematic classification of gallbladder stones[J]. PLoS One, 2013, 8(10):e74887.
[7] KIM G, MALAYAMAN S N, GREEN M S. Use of methyl tert-butyl ether for the treatment of refractory intrahepatic biliary strictures and bile casts: a modern perspective[J]. Case Rep Surg, 2015, 2015:408175.
[8] 郭玉宁, 王天懿, 杨昭徐. 胆结石接触溶石剂的临床研究[J]. 国外医学:内科学分册, 2003, 30(10):435-437.
[9] ZAKKO S F, SCIRICA J C, GUTTERMUTH M C, et al. Ethyl propionate is more effective and less cytotoxic than methyl tert-butyl ether for topical gallstone dissolution[J]. Gastroenterology, 1997, 113(1):232-237.
[10] SUN J. D-Limonene: safety and clinical applications[J]. Altern Med Rev, 2007, 12(3):259-264.
[11] STERNAL R S, DAVIS M A. In vitro dissolution of cholesterol gallstones[J]. Invest Radiol, 1992,27(12):1040-1043.
[12] IGIMI H, TAMURA R, TORAISHI K, et al. Medical dissolution of gallstones. Clinical experience of d-limonene as a simple, safe, and effective solvent[J]. Dig Dis Sci, 1991,36(2):200-208.
[13] PALMER K R, HOFMANN A F. Intraductal mono-octanoin for the direct dissolution of bile duct stones: experience in 343 patients[J]. Gut, 1986, 27(2):196-202.
[14] KELLY E, WILLIAMS J D, ORGAN C H. A history of the dissolution of retained choledocholithiasis[J]. Am J Surg, 2000, 180(2):86-98.
[15] NIJHAWAN S, AGARWAL V, SHARMA D, et al. Evaluation of garlic oil as a contact dissolution agent for gallstones: comparison with monooctanoin[J]. Trop Gastroenterol, 2000,21(4):177-179.
[16] SOHRABI A, MAX M H, HERSHEY C D. Cholate sodium infusion for retained common bile duct stones[J]. Arch Surg, 1979, 114(10):1169-1172.
[17] FURNIVAL C M, BURNETT W, GREEN M K, et al. In-vitro studies of gallstone dissolution: the effect of added heparin in bile salt solutions[J]. Aust N Z J Surg, 1977, 47(6):828-831.
[18] CHRISTIANSEN L A, SCHERSTEN T, BURCHARTH F, et al. Treatment of retained bile duct calculi with T-tube infusion of sodium cholate and heparin[J]. Scand J Gastroenterol, 1977, 12(3):337-339.
[19] MODI R P, JAIN T C, BAID J C, et al. Dissolution of gall-stones in vitro[J]. J Indian Med Assoc, 1991,89(5):129-132.
[20] BOGARDUS J B. Liquid crystalline phase formation by cholesterol in aqueous fatty acid salt solutions[J]. Hepatology, 1984,4(5 Suppl): 148S-150S.
[21] WOSIEWITZ U, SABINSKI F, HAUS C, et al. Experimental dissolution of pigment gallstone material using alkaline EDTA and adjuvant bile salts/non-bile salt detergents, thiols and urea, with respect to local chemolitholysis[J]. J Hepatol, 1992, 14(1):7-15.
[22] KOLLERUP M B, HILSCHER M, ZETNER D, et al. Adverse reactions of dimethyl sulfoxide in humans: a systematic review[J]. F1000Res, 2018, 7:1746.
[23] LIN X, CHOU T, LIN P, et al. Chemical dissolution of gallstones in Taiwan: an in vitro study[J]. J Gastroen Hepatol, 1994,9(2):143-147.
[24] IGIMI H, ASAKAWA S, TAMURA R, et al. DMSO preparation as a direct solubilizer of calcium bilirubinate stones[J]. Hepatogastroenterology, 1994, 41(1):65-69.
[25] ASAKAWA S, IGIMI H, SHIMURA H. A new direct solubilizer for bilirubinate calcium stones[J]. Nihon Geka Gakkai Zasshi, 1983, 84(10):1072-1083.
[26] NEOPTOLEMOS J P, HOFMANN A F, MOOSSA A R. Chemical treatment of stones in the biliary tree[J]. Brit J Surg, 1986, 73(7):515-524.
[27] SMITH B F, LAMONT J T. Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones[J]. J Clin Invest, 1985,76(2):439-445.
[28] CHENG J S, LAI K H, LO G H, et al. In vitro dissolution of cholesterol and brown pigmented gallstones: a comparison of MTBE, DMSO and BA-EDTA[J]. Zhonghua Yi Xue Za Zhi (Taipei), 2000, 63(9):667-672.
[29] YAMAMOTO F, IGIMI H. Direct gallstone dissolution therapy with GS-100[J]. Nihon Rinsho, 1993,51(7):1791-1796.
[30] IGIMI H, WATANABE D, YAMAMOTO F, et al. A useful cholesterol solvent for medical dissolution of gallstones[J]. Gastroenterol Jpn, 1992, 27(4):536-545.
[31] LIM M Y, CHOU T C, LIN X Z, et al. Enhanced dissolution of gallstone by combining ethanol with two commonly used cholelitholytic solvents[J]. Hepatogastroenterology, 1999, 46(26):758-761.
[32] CHEN Y K, YEH J H, LIN C L, et al. Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study[J]. J Gastroenterol, 2014,49(5): 923-931. |
